254 related articles for article (PubMed ID: 27263775)
1. [Immune pathophysiology of acquired aplastic anemia].
Ishiyama K
Rinsho Ketsueki; 2016 May; 57(5):525-30. PubMed ID: 27263775
[TBL] [Abstract][Full Text] [Related]
2. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutations in Aplastic Anemia.
Mufti GJ; Marsh JCW
Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
[TBL] [Abstract][Full Text] [Related]
4. [Immune pathophysiology of bone marrow failure].
Hosokawa K
Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
[TBL] [Abstract][Full Text] [Related]
5. [Acquired aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2019; 60(5):417-422. PubMed ID: 31168007
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
[TBL] [Abstract][Full Text] [Related]
7. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Feng X; Chuhjo T; Sugimori C; Kotani T; Lu X; Takami A; Takamatsu H; Yamazaki H; Nakao S
Blood; 2004 Oct; 104(8):2425-31. PubMed ID: 15217832
[TBL] [Abstract][Full Text] [Related]
8. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
10. Immune mechanism of aplastic anemia.
Nakao S
Int J Hematol; 1997 Aug; 66(2):127-34. PubMed ID: 9277043
[TBL] [Abstract][Full Text] [Related]
11. Immune pathophysiology of aplastic anemia.
Nakao S; Feng X; Sugimori C
Int J Hematol; 2005 Oct; 82(3):196-200. PubMed ID: 16207590
[TBL] [Abstract][Full Text] [Related]
12. Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.
Nowak J; Wozniak J; Mendek-Czajkowska E; Dlugokecka A; Mika-Witkowska R; Rogatko-Koros M; Graczyk-Pol E; Marosz-Rudnicka A; Dziopa J; Golec A; Kopec-Szlezak J; Warzocha K
Cell Biochem Biophys; 2013 Apr; 65(3):321-33. PubMed ID: 23076633
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S; Pagliuca S; Risitano AM
Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
[TBL] [Abstract][Full Text] [Related]
14. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia.
Nakao S; Takami A; Takamatsu H; Zeng W; Sugimori N; Yamazaki H; Miura Y; Ueda M; Shiobara S; Yoshioka T; Kaneshige T; Yasukawa M; Matsuda T
Blood; 1997 May; 89(10):3691-9. PubMed ID: 9160674
[TBL] [Abstract][Full Text] [Related]
15. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
16. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
17. [Role of CD8(+)T cells and their secreted cytokines in the pathogenesis of aplastic anemia].
Jiang BL; Li JP; Li WQ; Feng JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):569-72. PubMed ID: 24763045
[TBL] [Abstract][Full Text] [Related]
18. The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited.
Schoettler ML; Nathan DG
Hematol Oncol Clin North Am; 2018 Aug; 32(4):581-594. PubMed ID: 30047412
[TBL] [Abstract][Full Text] [Related]
19. Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes.
Risitano AM; Maciejewski JP; Selleri C; Rotoli B
Curr Stem Cell Res Ther; 2007 Jan; 2(1):39-52. PubMed ID: 18220891
[TBL] [Abstract][Full Text] [Related]
20. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia.
Li JP; Zheng CL; Han ZC
Crit Rev Oncol Hematol; 2010 Aug; 75(2):79-93. PubMed ID: 20045349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
